Matthew J. D'Onofrio - 08 Feb 2023 Form 4 Insider Report for Evoke Pharma Inc (EVOK)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EVOK	Stock Option (Right to Buy)	Award	$0	+25,000		$0.000000	25,000	08 Feb 2023	Common Stock	25,000	$4.01	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The total number of shares of common stock subject to the option vests on the four-year anniversary of the date of grant, subject to the reporting person's continuous service to the issuer on such vesting date.